Clopidogrel Versus Cilostazol in Ischemic Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

870

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

July 1, 2024

Study Completion Date

August 1, 2024

Conditions
Ischemic Stroke
Interventions
DRUG

Clopidogrel tablet

Efficacy and safety of a 300mg loading dose of clopidogrel administered within 24 hours of first-ever ischemic stroke followed by 75mg daily for 3 months will be assessed through NIHSS, mRS, duration of hospital stay, new ischemic stroke, and possible adverse effects.

DRUG

Cilostazol 100 MG

Efficacy and safety of 200 mg cilostazole followed by 100 mg twice daily for 3 months will be assessed through NIHSS, mRS, duration of hospital stay, new ischemic stroke, and possible adverse effects.

Trial Locations (1)

33511

Kafr Elsheikh University Hospital, Kafr ash Shaykh

All Listed Sponsors
lead

Kafrelsheikh University

OTHER